Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-23

FDA Approved: RANOLAZINE — Original Application (SunGen Pharma LLC)

View source ↗

Summary

FDA approves SunGen Pharma LLC's original application for a generic ranolazine product (Ranolazine) to treat chronic angina.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranolazine (ranolazine)

Snippet

ORIG AP for RANOLAZINE (RANOLAZINE)